A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

NCT05201781 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

295

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Cilta-cel

Sponsor

Janssen Research & Development, LLC